Deciphering the role of heterozygous mutations in genes associated with parkinsonism.
about
Parkinson's disease: from monogenic forms to genetic susceptibility factorsBiochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1)Genetics of Parkinson's disease - a clinical perspectiveGene-environment interactions: key to unraveling the mystery of Parkinson's diseaseOxidative stress and regulation of Pink1 in zebrafish (Danio rerio)Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT scoreParkinson's Disease and Cognitive ImpairmentThe effects of oxidative stress on parkin and other E3 ligases.Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin.Parkin disease: a clinicopathologic entity?Dynamic and redundant regulation of LRRK2 and LRRK1 expression.Analysis of Nigerians with apparently sporadic Parkinson disease for mutations in LRRK2, PRKN and ATXN3.LRRK2 in Parkinson's disease - drawing the curtain of penetrance: a commentary.Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype.DJ-1, PINK1, and their effects on mitochondrial pathwaysCancer and neurodegeneration: between the devil and the deep blue sea.Phase analysis identifies compound heterozygous deletions of the PARK2 gene in patients with early-onset Parkinson disease.Unravelling the role of defective genes.Parkin (PARK 2) mutations are rare in Czech patients with early-onset Parkinson's diseaseDNAJC6 Mutations Associated With Early-Onset Parkinson's Disease.Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.Defects in tongue papillae and taste sensation indicate a problem with neurotrophic support in various neurological diseases.A meta-analysis of the relationship of the Parkin p.Val380Leu polymorphism to Parkinson's disease.The 'thousand-dollar genome': an ethical exploration.Genetic neuropathology of Parkinson's disease.Transgenic animal models of neurodegeneration based on human genetic studies.Early exposure to paraquat sensitizes dopaminergic neurons to subsequent silencing of PINK1 gene expression in mice.Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease.Compensatory premotor activity during affective face processing in subclinical carriers of a single mutant Parkin allele.Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups.Brain Connectivity Changes in Autosomal Recessive Parkinson Disease: A Model for the Sporadic FormParkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and controlThe genetics of Parkinson's disease: progress and therapeutic implicationsAn intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer's disease brain samples.Phenotypic and molecular analyses of primary lateral sclerosis.Characterization of PINK1 processing, stability, and subcellular localization.P268S in NOD2 associates with susceptibility to Parkinson's disease in Chinese population.Animal models of Parkinson's disease progression
P2860
Q22242870-ADF73752-530D-4A11-A61E-301DDA72E8ACQ24307730-01B3641A-9BBD-451E-8ED5-14EC95B12487Q27022109-3B1AAFEA-7D4B-4930-9713-4954EC61B162Q28388674-9AE2A0C1-0C1D-4517-83AE-DC673FDDF066Q28535834-8A82B0C5-271C-45CC-A212-5FCB15BEC075Q29048624-8F1BDA0A-9EE3-4260-8381-FAFBDF1D7D60Q30239814-1E94700B-D9CF-4CE0-BF22-2B13BBD015E6Q30273796-55B90C59-7DFB-4425-A5CB-B15E4DEBBC28Q30492449-6E101071-404D-4EEE-928E-B37736EF251DQ30594306-17D82A7E-1128-41AD-AB32-AC5E3F707831Q33307626-2578925C-6C0D-4C46-82F6-1F616957C84BQ33377437-A7E52477-4893-4091-B442-EF13D4555233Q33382857-27CD52A5-C24C-4D3D-9FED-98994521481EQ33577056-40F19A29-46BF-4E0F-A746-DDE423578E03Q33652645-1908CCB1-9728-4CA6-87B4-B13F788D957FQ33733264-6EFF5977-C68A-4863-8E90-3B0DF144CADCQ33784620-2F2CECFE-182D-4546-B08F-57AEACB2318AQ34181728-5D7DA2B7-51A1-4310-BF2E-5039DB4D622FQ34201811-7BDF4371-513C-4189-B661-632DFFD71C32Q34215600-89A86670-1D82-4940-96A0-08BDCFB8997EQ34500305-CDD27088-00F8-46FC-988D-2212775B6A69Q34555482-4EEC6E46-9099-41E4-82A6-FDF543243FA5Q34588289-1D16C758-6E78-4FAA-8443-5E41D5AEA8ECQ34597756-17DF5F7F-26BA-48B0-BA3B-6B9CC3C7374EQ34724819-56F292AF-148D-4273-9167-97A9F2AB4EB0Q34825312-5D0859DE-D7CB-4726-B9F4-E3139E14D8C6Q34890228-C1C7A117-CEE3-41BB-8673-43B6ACD409BBQ35479978-2608998F-875B-4201-AB8A-27649EC38484Q35679526-BB430809-D9FA-466A-AE1A-3C6258BC22DFQ35888655-D5814567-167A-41D6-8382-B0A914F6F7A8Q35898027-C1E6A521-81BA-437E-B4F1-C9FB2236BD09Q35981624-64C9645F-C9DF-4AEC-A317-716DE1082C51Q36176035-08F5B82A-8E86-4790-B9A8-8AC852F9EC10Q36617539-6570B20D-E3BB-42C7-959D-E10FAB75EA8BQ36626825-39D6F41B-5C07-4E0E-86E5-54B981A97B1CQ36683066-6E3DA77A-625D-425A-BCC5-83901D26301BQ36766094-A2F392A3-1C4A-4436-9667-116DD1BD9E6CQ36802214-B692A936-AC10-4A9E-BBBB-40670CD76606Q36871156-C2C36AF1-2C08-4927-A350-A6E2A1CA63FCQ36924624-84D56F21-0684-476E-8BF0-57203E41487E
P2860
Deciphering the role of heterozygous mutations in genes associated with parkinsonism.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Deciphering the role of heterozygous mutations in genes associated with parkinsonism.
@en
type
label
Deciphering the role of heterozygous mutations in genes associated with parkinsonism.
@en
prefLabel
Deciphering the role of heterozygous mutations in genes associated with parkinsonism.
@en
P50
P1433
P1476
Deciphering the role of heterozygous mutations in genes associated with parkinsonism.
@en
P2093
Katja Lohmann-Hedrich
Michael G Schlossmacher
P304
P356
10.1016/S1474-4422(07)70174-6
P577
2007-07-01T00:00:00Z